PMID

Data

Article Title

Organization

Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs.

Donghua University

Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Uppsala University

Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.

The University Of Mississippi

Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.

Universit£

2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.

Abbott Laboratories

Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.

Uppsala University

Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.

Uppsala University

Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds.

Uppsala University

Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor.

Laboratoires Fournier

The Other Angiotensin II Receptor: AT

Centre Hospitalier Universitaire Vaudois (Chuv) And University Of Lausanne (Unil

Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.

Taisho Pharmaceutical

N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.

Pudue Pharma Discovery Research

Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.

Shinshu University

ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.

Abbott Laboratories

Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.

Parke-Davis Pharmaceutical Research

RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist.

Syntex Discovery Research